18 research outputs found

    Nondisjunction and transmission ratio distortion ofChromosome 2 in a (2.8) Robertsonian translocation mouse strain

    Get PDF
    Aneuploidy results from nondisjunction of chromosomes in meiosis and is the leading cause of developmental disabilities and mental retardation in humans. Therefore, understanding aspects of chromosome segregation in a genetic model is of value. Mice heterozygous for a (2.8) Robertsonian translocation were intercrossed with chromosomally normal mice and Chromosome 2 was genotyped for number and parental origin in 836 individuals at 8.5 dpc. The frequency of nondisjunction of this Robertsonian chromosome is 1.58%. Trisomy of Chromosome 2 with two maternally derived chromosomes is the most developmentally successful aneuploid karyotype at 8.5 dpc. Trisomy of Chromosome 2 with two paternally derived chromosomes is developmentally delayed and less frequent than the converse. Individuals with maternal or paternal uniparental disomy of Chromosome 2 were not detected at 8.5 dpc. Nondisjunction events were distributed randomly across litters, i.e., no evidence for clustering was found. Transmission ratio distortion is frequently observed in Robertsonian chromosomes and a bias against the transmission of the (2.8) Chromosome was detected. Interestingly, this was observed for female and male transmitting parents

    Microarray data reveal relationship between Jag1 and Ddr1 in mouse liver.

    Get PDF
    Alagille syndrome is an autosomal dominant disorder involving bile duct paucity and cholestasis in addition to cardiac, skeletal, ophthalmologic, renal and vascular manifestations. Mutations in JAG1, encoding a ligand in the Notch signaling pathway, are found in 95% of patients meeting clinical criteria for Alagille syndrome. In order to define the role of Jag1 in the bile duct developmental abnormalities seen in ALGS, we previously created a Jag1 conditional knockout mouse model. Mice heterozygous for the Jag1 conditional and null alleles demonstrate abnormalities in postnatal bile duct growth and remodeling, with portal expansion and increased numbers of malformed bile ducts. In this study we report the results of microarray analysis and identify genes and pathways differentially expressed in the Jag1 conditional/null livers as compared with littermate controls. In the initial microarray analysis, we found that many of the genes up-regulated in the Jag1 conditional/null mutant livers were related to extracellular matrix (ECM) interactions, cell adhesion and cell migration. One of the most highly up-regulated genes was Ddr1, encoding a receptor tyrosine kinase (RTK) belonging to a large RTK family. We have found extensive co-localization of Jag1 and Ddr1 in bile ducts and blood vessels in postnatal liver. In addition, co-immunoprecipitation data provide evidence for a novel protein interaction between Jag1 and Ddr1. Further studies will be required to define the nature of this interaction and its functional consequences, which may have significant implications for bile duct remodeling and repair of liver injury

    Molecular analysis of nondisjunction in mice heterozygous for a Robertsonian translocation.

    No full text
    A Robertsonian translocation results in a metacentric chromosome produced by the fusion of two acrocentric chromosomes. Rb heterozygous mice frequently generate aneuploid gametes and embryos, providing a good model for studying meiotic nondisjunction. We intercrossed mice heterozygous for a (7.18) Robertsonian translocation and performed molecular genotyping of 1812 embryos from 364 litters with known parental origin, strain, and age. Nondisjunction events were scored and factors influencing the frequency of nondisjunction involving chromosomes 7 and 18 were examined. We concluded the following: 1. The frequency of nondisjunction among 1784 embryos (3568 meioses) was 15.9%. 2. Nondisjunction events were distributed nonrandomly among progeny. This was inferred from the distribution of the frequency of trisomics and uniparental disomics (UPDs) among all litters. 3. There was no evidence to show an effect of maternal or paternal age on the frequency of nondisjunction. 4. Strain background did not play an appreciable role in nondisjunction frequency. 5. The frequency of nondisjunction for chromosome 18 was significantly higher than that for chromosome 7 in males. 6. The frequency of nondisjunction for chromosome 7 was significantly higher in females than in males. These results show that molecular genotyping provides a valuable tool for understanding factors influencing meiotic nondisjunction in mammals

    Timecourse of Extracellular Matrix & Adhesion PCR Array Gene Expression.

    No full text
    <p>p-values listed are for the 4 week data only.</p><p>Real-time PCR was employed using the Extracellular Matrix & Adhesion molecules PCR Array to investigate the changes in gene expression related to fibrosis and injury over time. The data support a repair mechanism is likely active between the peak fibrotic phenotype at 4 weeks of age and 12–16 weeks of age.</p

    Jag1 and Ddr1 are co-localized in hepatic artery and bile duct at 2 weeks of age.

    No full text
    <p>A, B, C. Ddr1 (red) and Jag1 (blue) are expressed in hepatic artery in the mouse liver at 2 weeks of age (HA, panel C). While Jag1 is highly expressed in the endothelium, Ddr1 expression appears to be confined to the smooth muscle wall of the blood vessel. Ddr1 and Jag1 are both expressed in areas of intercellular junctions within bile ducts (arrows, panels A and B). (Scale bar in [C] = 25 μ for [A] through [C]).</p

    Time course of <i>Jag1</i> gene expression in <i>Jag1</i> conditional/null mouse liver samples.

    No full text
    <p>Measurement of <i>Jag1</i> expression in whole mouse liver by real time PCR reveals that <i>Jag1</i> expression is significantly decreased in <i>Jag1</i> conditional/null mutant livers at newborn and 2 week time points. At 3 and 4 weeks of age, <i>Jag1</i> expression is not significantly decreased in whole liver, possibly corresponding to increased <i>Jag1</i> expression in other cell types within the liver.</p
    corecore